RLMD short interest
Relmada Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 13,424,126 |
|---|---|
| Change vs prior report | -1,039,551 (-7.2%) |
| Change over six months | +122.2% |
| Days to cover | 12.99 (sector: 3.78) |
| Average daily volume | 1,033,660 |
| Rank in Healthcare | #57 of 922 by days to cover |
RLMD short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 13,424,126 | -7.2% | 12.99 | 1,033,660 |
| 2026-09-15 | 14,463,677 | +6.3% | 9.25 | 1,564,249 |
| 2026-08-31 | 13,602,542 | +5.5% | 17.71 | 768,191 |
| 2026-08-14 | 12,893,514 | -4.9% | 9.35 | 1,379,343 |
| 2026-07-31 | 13,563,773 | +4.4% | 7.79 | 1,741,985 |
| 2026-07-15 | 12,990,487 | +22.0% | 8.46 | 1,535,339 |
| 2026-06-30 | 10,647,441 | +75.7% | 3.07 | 3,471,338 |
| 2026-06-15 | 6,060,018 | +3.8% | 4.43 | 1,369,203 |
| 2026-05-29 | 5,841,074 | +6.4% | 6.07 | 961,523 |
| 2026-05-15 | 5,487,630 | +2.6% | 6.11 | 898,231 |
| 2026-04-30 | 5,348,739 | -13.6% | 3.87 | 1,380,528 |
| 2026-04-15 | 6,193,292 | +2.5% | 4.78 | 1,295,907 |
| 2026-03-31 | 6,042,204 | +61.9% | 4.45 | 1,357,138 |
| 2026-03-13 | 3,731,201 | +346.2% | 1.00 | 5,015,092 |
| 2026-02-27 | 836,254 | -24.8% | 1.27 | 658,665 |
| 2026-02-13 | 1,111,415 | -11.5% | 1.96 | 568,234 |
| 2026-01-30 | 1,256,360 | -12.3% | 2.29 | 548,896 |
| 2026-01-15 | 1,433,056 | +3.2% | 2.75 | 521,262 |
| 2025-12-31 | 1,388,226 | +41.5% | 1.57 | 881,975 |
| 2025-12-15 | 980,736 | +26.9% | 1.00 | 1,087,977 |
| 2025-11-28 | 772,889 | -18.3% | 1.00 | 998,082 |
| 2025-11-14 | 946,511 | +84.1% | 1.00 | 3,328,999 |
| 2025-10-31 | 514,106 | -8.6% | 3.11 | 165,215 |
| 2025-10-15 | 562,426 | -32.7% | 1.32 | 424,761 |
| 2025-09-30 | 835,693 | +17.5% | 1.73 | 483,945 |
import finzdata as yf
yf.Ticker("RLMD").short_interest # every report since 2017
yf.Client().short_interest(["RLMD"], start="2018-01-01")Healthcare short interest · RLMD price history · Who owns RLMD · All short interest